Efficacy of Vitamin B6 in Lithium-Associated Tremor: A Case Series.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28099184)

Published in J Clin Psychopharmacol on January 18, 2017

Authors

Manuel Dias Alves1, Laure Varin, Laura M Fiori, Bruno Etain, Jean-Michel Azorin, Raoul Belzeaux

Author Affiliations

1: Department of Psychiatry, Assistance Publique Hôpitaux de Marseille, Marseille, France; AP-HP, Hôpitaux Universitaires Henri Mondor, Pôle de Psychiatrie et d'Addictologie, Créteil, France; McGill Group for Suicide Studies, Douglas Mental Health University Institute, Department of Psychiatry, McGill University, Montreal, Quebec, Canada; AP-HP, GH Saint-Louis-Lariboisière-Fernand-Widal, Pôle Neurosciences, Université Paris Diderot, INSERM UMR-S 1144, Paris and Fondation FondaMental, Créteil, France; Department of Psychiatry, Assistance Publique Hôpitaux de Marseille, Marseille and Fondation FondaMental, Créteil, France Department of Psychiatry, Assistance Publique Hôpitaux de Marseille, Marseille and Fondation FondaMental, Créteil, France and McGill Group for Suicide Studies, Douglas Mental Health University Institute, Department of Psychiatry, McGill University, Montreal, Quebec, Canada. raoul.belzeaux@ap-hm.fr.

Articles by these authors

Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02

International Society for Bipolar Disorders Task Force on Suicide: meta-analyses and meta-regression of correlates of suicide attempts and suicide deaths in bipolar disorder. Bipolar Disord (2014) 4.10

Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet (2010) 3.72

Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder. Am J Hum Genet (2011) 2.71

Mixed features in patients with a major depressive episode: the BRIDGE-II-MIX study. J Clin Psychiatry (2015) 2.15

Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: the BRIDGE study. Arch Gen Psychiatry (2011) 2.10

The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry (2013) 1.97

Rates and correlates of employment in people with schizophrenia in the UK, France and Germany. Br J Psychiatry (2007) 1.57

Biosynthesis of the N-linked glycan in Campylobacter jejuni and addition onto protein through block transfer. J Bacteriol (2006) 1.46

Burden on caregivers of people with schizophrenia: comparison between Germany and Britain. Br J Psychiatry (2007) 1.17

Commonality and biosynthesis of the O-methyl phosphoramidate capsule modification in Campylobacter jejuni. J Biol Chem (2007) 1.16

Anxiety disorders in 318 bipolar patients: prevalence and impact on illness severity and response to mood stabilizer. J Clin Psychiatry (2003) 1.11

Trait-related decision-making impairment in the three phases of bipolar disorder. Biol Psychiatry (2011) 1.09

A social network analysis of healthcare professional relationships in a French hospital. Int J Health Care Qual Assur (2010) 1.01

Bilateral decrease in ventrolateral prefrontal cortex activation during motor response inhibition in mania. J Psychiatr Res (2008) 1.00

The lifetime and past-year prevalence of dual diagnosis in people with schizophrenia across Europe: findings from the European Schizophrenia Cohort (EuroSC). Eur Arch Psychiatry Clin Neurosci (2012) 0.97

Lack of insight may predict impaired decision making in manic patients. Bipolar Disord (2008) 0.96

The architecture of cognitive control in schizophrenia. Brain (2008) 0.95

Differential responses to emotional interference in paranoid schizophrenia and bipolar mania. Psychopathology (2010) 0.95

Profiling brain expression of the spermidine/spermine N1-acetyltransferase 1 (SAT1) gene in suicide. Am J Med Genet B Neuropsychiatr Genet (2009) 0.94

Validating antidepressant-associated hypomania (bipolar III): a systematic comparison with spontaneous hypomania (bipolar II). J Affect Disord (2003) 0.94

Bipolar patients with suicidal behavior: toward the identification of a clinical subgroup. J Clin Psychiatry (2004) 0.94

Clozapine for the treatment of schizophrenia. Expert Opin Pharmacother (2012) 0.92

The European Schizophrenia Cohort (EuroSC): a naturalistic prognostic and economic study. Soc Psychiatry Psychiatr Epidemiol (2005) 0.92

Residential area and social contacts in schizophrenia. Results from the European Schizophrenia Cohort (EuroSC). Soc Psychiatry Psychiatr Epidemiol (2007) 0.91

Familial resemblance for executive functions in families of schizophrenic and bipolar patients. Psychiatry Res (2006) 0.91

Remission from mania is associated with a decrease in amygdala activation during motor response inhibition. Bipolar Disord (2009) 0.91

Correlations between objective and subjective sleep and circadian markers in remitted patients with bipolar disorder. Chronobiol Int (2014) 0.91

Reconsideration of bipolar disorder as a developmental disorder: importance of the time of onset. J Physiol Paris (2013) 0.90

Relapse according to antipsychotic treatment in schizophrenic patients: a propensity-adjusted analysis. BMC Psychiatry (2011) 0.90

Reduced brain activation in euthymic bipolar patients during response inhibition: an event-related fMRI study. Psychiatry Res (2009) 0.89

A prospective study of Quality of life in schizophrenia in three European countries. Schizophr Res (2007) 0.89

Correlates of subjective quality of life in people with schizophrenia: findings from the EuroSC study. J Nerv Ment Dis (2008) 0.89

Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) Report. PLoS One (2013) 0.88

Effects of promoter methylation on increased expression of polyamine biosynthetic genes in suicide. J Psychiatr Res (2012) 0.87

Psychiatrists' awareness of adherence to antipsychotic medication in patients with schizophrenia: results from a survey conducted across Europe, the Middle East, and Africa. Patient Prefer Adherence (2013) 0.87

Circadian biomarkers, circadian genes and bipolar disorders. J Physiol Paris (2011) 0.87

New ways to classify bipolar disorders: going from categorical groups to symptom clusters or dimensions. Curr Psychiatry Rep (2010) 0.87

Mental disorders among homeless people admitted to a French psychiatric emergency service. Psychiatr Serv (2010) 0.87

Biomarkers of bipolar disorder: specific or shared with schizophrenia? Front Biosci (Elite Ed) (2013) 0.86

Blunted activation in right ventrolateral prefrontal cortex during motor response inhibition in schizophrenia. Schizophr Res (2007) 0.86

Kleine-Levin syndrome and bipolar disorder: a differential diagnosis of recurrent and resistant depression. Bipolar Disord (2013) 0.85

Suicidal attempts in bipolar disorder: results from an observational study (EMBLEM). Bipolar Disord (2011) 0.85

Social phobia is associated with suicide attempt history in bipolar inpatients. Bipolar Disord (2007) 0.85

Association between the PPP3CC gene, coding for the calcineurin gamma catalytic subunit, and bipolar disorder. Behav Brain Funct (2008) 0.85

Predictors of employment status change over 2 years in people with schizophrenia living in Europe. Epidemiol Psichiatr Soc (2010) 0.85

A prospective study of health care resource utilisation and selected costs of schizophrenia in France. BMC Health Serv Res (2012) 0.84

Young Mania Rating Scale: how to interpret the numbers? Determination of a severity threshold and of the minimal clinically significant difference in the EMBLEM cohort. Int J Methods Psychiatr Res (2013) 0.84

Evidence of altered polyamine concentrations in cerebral cortex of suicide completers. Neuropsychopharmacology (2010) 0.84

Polymorphism of Toll-like receptor 4 gene in bipolar disorder. J Affect Disord (2013) 0.84

Association between brain-derived neurotrophic factor gene and a severe form of bipolar disorder, but no interaction with the serotonin transporter gene. Bipolar Disord (2008) 0.84

[Selecting material to develop an emotional Stroop test adapted to schizophrenia and bipolar disorders]. Can J Psychiatry (2008) 0.83

Regulatory role of miRNAs in polyamine gene expression in the prefrontal cortex of depressed suicide completers. Int J Neuropsychopharmacol (2013) 0.83

Cost-effectiveness of asenapine in the treatment of bipolar I disorder patients with mixed episodes. J Med Econ (2014) 0.83

Age at onset in bipolar I affective disorder in the USA and Europe. World J Biol Psychiatry (2011) 0.83

Bipolar disorder with seasonal pattern: clinical characteristics and gender influences. Chronobiol Int (2013) 0.81

Psychiatrists' perceptions of potential reasons for non- and partial adherence to medication: results of a survey in bipolar disorder from eight European countries. J Affect Disord (2012) 0.80

[Early onset bipolar disorder: validation from admixture analyses and biomarkers]. Can J Psychiatry (2013) 0.80

Characteristics and profiles of bipolar I patients according to age-at-onset: findings from an admixture analysis. J Affect Disord (2013) 0.80

Gene x environment interactions in schizophrenia and bipolar disorder: evidence from neuroimaging. Front Psychiatry (2013) 0.80

Frequent visits to a French psychiatric emergency service: diagnostic variability in psychotic disorders. Psychiatr Serv (2011) 0.80

Childhood maltreatment and stress-related psychopathology: the epigenetic memory hypothesis. Curr Pharm Des (2015) 0.80

Stroop and emotional Stroop interference in unaffected relatives of patients with schizophrenic and bipolar disorders: distinct markers of vulnerability? World J Biol Psychiatry (2009) 0.80

Transcultural validity of the Hypomania Checklist-32 (HCL-32) in patients with major depressive episodes. Bipolar Disord (2013) 0.79

Depressive residual symptoms are associated with lower adherence to medication in bipolar patients without substance use disorder: results from the FACE-BD cohort. J Affect Disord (2013) 0.79

Combination therapy for manic phases: a critical review of a common practice. CNS Neurosci Ther (2012) 0.79

Sleep- and circadian rhythm-associated pathways as therapeutic targets in bipolar disorder. Expert Opin Ther Targets (2015) 0.79

A French network of bipolar expert centres: a model to close the gap between evidence-based medicine and routine practice. J Affect Disord (2010) 0.79

Genetic heterogeneity according to age at onset in bipolar disorder: a combined positional cloning and candidate gene approach. Am J Med Genet B Neuropsychiatr Genet (2012) 0.79

European collaborative study of early-onset bipolar disorder: Evidence for genetic heterogeneity on 2q14 according to age at onset. Am J Med Genet B Neuropsychiatr Genet (2010) 0.78

Is processing speed a valid cognitive endophenotype for bipolar disorder? J Affect Disord (2012) 0.78

Impact of switching or initiating antipsychotic treatment on body weight during a 6-month follow-up in a cohort of patients with schizophrenia. J Clin Psychopharmacol (2012) 0.78

Explained factors of suicide attempts in major depression. J Affect Disord (2010) 0.78

Mental Disorders among Children and Adolescents Admitted to a French Psychiatric Emergency Service. Emerg Med Int (2013) 0.78

Risperidone versus haloperidol for facial affect recognition in schizophrenia: findings from a randomised study. World J Biol Psychiatry (2009) 0.78

Negative Symptoms in Schizophrenia: Where We have been and Where We are Heading. CNS Neurosci Ther (2014) 0.77

Is comorbid borderline personality disorder in patients with major depressive episode and bipolarity a developmental subtype? Findings from the international BRIDGE study. J Affect Disord (2012) 0.77

Self-assessment and characteristics of mixed depression in the French national EPIDEP study. J Affect Disord (2012) 0.77

Monitoring candidate gene expression variations before, during and after a first major depressive episode in a 51-year-old man. BMC Psychiatry (2014) 0.76

Metabolic syndrome in a French cohort of patients with bipolar disorder: results from the FACE-BD cohort. J Clin Psychiatry (2014) 0.76

The European sertindole safety and exposure survey: a follow-up study of 8600 patients. Pharmacoepidemiol Drug Saf (2007) 0.76

High-resolution capillary gas chromatography in combination with mass spectrometry for quantification of three major polyamines in postmortem brain cortex. Methods Mol Biol (2011) 0.76

Circadian biomarkers in patients with bipolar disorder: promising putative predictors of lithium response. Int J Bipolar Disord (2014) 0.76

Risks associated with gender differences in bipolar I disorder. J Affect Disord (2013) 0.76

Melatonin and Melatonin Agonists as Adjunctive Treatments in Bipolar Disorders. Curr Pharm Des (2015) 0.75

Mood disorders are highly prevalent but underdiagnosed among patients seeking bariatric surgery. Obes Surg (2015) 0.75

MRI exploration of pineal volume in bipolar disorder. J Affect Disord (2011) 0.75

BRIDGE Study Warrants Critique-Reply. Arch Gen Psychiatry (2012) 0.75

[A randomized controlled study on the impact of pharmacoeducation on a French patient population with schizophrenic and schizoaffective disorders]. Can J Psychiatry (2010) 0.75

Longitudinal monitoring of the serotonin transporter gene expression to assess major depressive episode evolution. Neuropsychobiology (2015) 0.75

DSM-IV diagnosis in depressed primary care patients with previous psychiatric ICD-10 bipolar disorder. J Affect Disord (2013) 0.75

Treatment of Comorbid Bipolar Disorder Improves Disabilities and Neuropsychological Functioning in DiGeorge Syndrome: A Case Report. J Clin Psychopharmacol (2017) 0.75

Baclofen and risperidone association increases dramatically triglycerides level. Alcohol Alcohol (2013) 0.75

The HLA-G low expressor genotype is associated with protection against bipolar disorder. Hum Immunol (2012) 0.75